Changes in cholesterol levels in women after coronary artery bypass surgery

被引:3
作者
Allen, JK [1 ]
机构
[1] Johns Hopkins Univ, Sch Nursing, Baltimore, MD 21205 USA
来源
HEART & LUNG | 1999年 / 28卷 / 04期
关键词
D O I
10.1016/S0147-9563(99)70073-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE: To examine the predictors of change in cholesterol levels in a cohort of women between the time of surgery and 1 year after coronary artery bypass graft surgery (CABG). DESIGN AND SETTING: This study was a prospective, descriptive study held at a Mid-Atlantic tertiary care medical center. METHODS: Lipid profiles, lifestyle behaviors, and other major coronary risk factors were measured at the time of surgery and again 12 months later from a consecutive convenience sample of 130 women who underwent first-lime, isolated CABG. RESULTS: The sample population was 24% black and 76% white and had a mean age of 65 years and an average of 11 years of education. Although no statistically significant changes in cholesterol levels were observed, a majority (55%) of women had increases in total cholesterol level, whereas 45% had decreased total cholesterol level between baseline and 1 year of follow-up. After controlling for preoperative cholesterol values, a change in cholesterol level was independently predicted by ejection fraction, smoking status, and body mass index. At 1 year, plasma lipoprotein levels were not optimally managed, with high proportions of values exceeding national guidelines for secondary prevention. CONCLUSIONS: Women continue to have high cholesterol levels after CABG, putting them at high risk for future coronary heart disease events. Effective secondary prevention programs targeting multiple lifestyle behaviors and adequate pharmacotherapy are needed.
引用
收藏
页码:270 / 275
页数:6
相关论文
共 25 条
[1]   CORONARY RISK-FACTORS IN WOMEN 6 MONTHS AFTER CORONARY-ARTERY BYPASS-GRAFTING [J].
ALLEN, JK ;
BLUMENTHAL, RS .
AMERICAN JOURNAL OF CARDIOLOGY, 1995, 75 (16) :1092-1095
[2]  
*AM HEART ASS, 1997, 1997 HEART STROK STA
[3]   BENEFICIAL-EFFECTS OF COMBINED COLESTIPOL-NIACIN THERAPY ON CORONARY ATHEROSCLEROSIS AND CORONARY VENOUS BYPASS GRAFTS [J].
BLANKENHORN, DH ;
NESSIM, SA ;
JOHNSON, RL ;
SANMARCO, ME ;
AZEN, SP ;
CASHINHEMPHILL, L .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1987, 257 (23) :3233-3240
[4]  
Block G, 1990, Epidemiology, V1, P58, DOI 10.1097/00001648-199001000-00013
[5]   A British cardiac society survey of the potential for the secondary prevention of coronary disease: ASPIRE (Action on Secondary Prevention through Intervention to Reduce Events) - Principal results [J].
Bowker, TJ ;
Clayton, TC ;
Ingham, J ;
McLennan, NR ;
Hobson, HL ;
Pyke, SDM ;
Schofield, B ;
Wood, DA .
HEART, 1996, 75 (04) :334-342
[6]   THE RELATION OF RISK-FACTORS TO THE DEVELOPMENT OF ATHEROSCLEROSIS IN SAPHENOUS-VEIN BYPASS GRAFTS AND THE PROGRESSION OF DISEASE IN THE NATIVE CIRCULATION - A STUDY 10 YEARS AFTER AORTOCORONARY BYPASS-SURGERY [J].
CAMPEAU, L ;
ENJALBERT, M ;
LESPERANCE, J ;
BOURASSA, MG ;
KWITEROVICH, P ;
WACHOLDER, S ;
SNIDERMAN, A .
NEW ENGLAND JOURNAL OF MEDICINE, 1984, 311 (21) :1329-1332
[7]  
CAMPEAU L, 1991, CARE PATIENT PREVIOU, P123
[8]   LOW RATE OF TREATMENT OF HYPERCHOLESTEROLEMIA BY CARDIOLOGISTS IN PATIENTS WITH SUSPECTED AND PROVEN CORONARY-ARTERY DISEASE [J].
COHEN, MV ;
BYRNE, MJ ;
LEVINE, B ;
GUTOWSKI, T ;
ADELSON, R .
CIRCULATION, 1991, 83 (04) :1294-1304
[9]   A CASE-MANAGEMENT SYSTEM FOR CORONARY RISK FACTOR MODIFICATION AFTER ACUTE MYOCARDIAL-INFARCTION [J].
DEBUSK, RF ;
MILLER, NH ;
SUPERKO, HR ;
DENNIS, CA ;
THOMAS, RJ ;
LEW, HT ;
BERGER, WE ;
HELLER, RS ;
ROMPF, J ;
GEE, D ;
KRAEMER, HC ;
BANDURA, A ;
GHANDOUR, G ;
CLARK, M ;
SHAH, RV ;
FISHER, L ;
TAYLOR, CB .
ANNALS OF INTERNAL MEDICINE, 1994, 120 (09) :721-729